Spectator on facebook

Spectator on facebook

CORPORATE BRIEFS

Slovakofarma reports net earnings of 224 million Sk at end of 3Q98

Slovakofarma Hlohovec, Slovakia's biggest pharmaceuticals producer, earned a net consolidated profit of 224 million Sk ($6.2 million) over nine months of this year, which is 53 million Sk up on net profit for 1H98. Before-tax profits were 399 million Sk ($11.08 million) on sales of 3.591 billion Sk ($100 million).

Slovakofarma's net profit last year was 344 million Sk, down 169 million Sk from 1996. Sales in 1997 were 4.57 billion Sk. The company's commercial plan for 1998 counts on consolidated sales of 5.5 billion Sk, and consolidated earnings are planned at 550 million Sk. Investments, including leasing, are to swallow up to 400 million Sk.

Slovakofarma is the largest, oldest, and most important pharmaceuticals company in Slovakia, and its domestic market share is 15%. It is one of the six largest pharmaceuticals companies in central and eastern Europe.

Top stories

In praise of concrete

It was once notorious for its drab tower blocks and urban crime, but Petržalka now epitomises modern Slovakia.

Petržalka is the epitome of communist-era architecture.

Slow down, fashion

Most people are unaware that buying too many clothes too harms the environment.

In shallow waters, experts are expendable

Mihál says that it is Sulík, the man whom his political opponents mocked for having a calculator for a brain, who “is pulling the party out of liberal waters and towards somewhere completely different”.

Richard Sulík is a man of slang.

Blog: Exploring 20th century military sites in Bratislava

It seems to be the fate of military sites and objects in Bratislava that none of them were ever used for the purposes they were built for - cavernas from WWI, bunkers from WWII, nuclear shelters or the anti-aircraft…

One nuclear shelter with a capacity for several hundred people now serves as a music club with suitable name Subclub (formerly U-club).